RESUMO
The hygroscopicities of calcium and magnesium salts strongly affect the environment and climate, but the aging products of these salts at high relative humidities (RHs) are still poorly understood. In this study, surface plasmon resonance microscopy (SPRM) was used to determine the hygroscopic growth factors (GFs) of Ca(NO3)2 and Mg(NO3)2 separately or mixed with galactose at different mass ratios at different RHs before and after aging. For all particles, the measured GFs showed no indication of deliquescence across the range of RHs tested, and overall hygroscopicity was clearly lower after than before aging. The Ca(NO3)2 and Mg(NO3)2 GFs at 90 % RH were 1.80 and 1.66, respectively, before aging and 1.33 and 1.42, respectively, after 4 h aging, meaning aging decreased the GFs by 26.11 % and 14.46 %, respectively. Aging decreased the hygroscopicity because insoluble or sparingly soluble substances (CaSO3, CaSO4, MgSO3) formed and strongly changed the overall hygroscopicity. For bicomponent aerosols with different mass ratios, the GFs (calculated using the Zdanovskii-Stokes-Robinson method) of the other components except galactose at 90 % RH after 1 h aging were all lower, respectively, than the measured GFs of pure Ca(NO3)2 and Mg(NO3)2 after aging for 1 h, especially with the mass ratio of 1:2, their GFs have decreased by 14.63 % and 7.50 %, respectively. Subsequently, Ion chromatograms indicated that the peak area ratio of SO42- to NO3- ratios were higher for the aged bicomponent particles than aged single-component particles, possibly because adding galactose improved the gas-liquid state stability during drying after the aging process and therefore promoted nitrate consumption and sulfate formation. The results indicated that organic components may play important roles in heterogeneous reactions between trace gases and multicomponent aerosols and should be considered in evaluating the impacts on submicron aerosol composition of high atmospheric SO2 concentrations at high humidities.
RESUMO
BACKGROUND: Oxaliplatin is an integral component of colorectal cancer treatment, but its use is limited by neurotoxicity. The Combined Oxaliplatin Neurotoxicity Prevention Trial (CONcePT) tested intermittent oxaliplatin (IO) administration and the use of concurrent calcium and magnesium salts (Ca/Mg), two modifications intended to reduce neurotoxicity and extend the duration of treatment. PATIENTS AND METHODS: In this trial involving double randomization, 140 patients were randomized to receive modified FOLFOX7 plus bevacizumab with IO (eight-cycle blocks of oxaliplatin treatment) versus continuous oxaliplatin (CO); and Ca/Mg versus placebo (pre- and postoxaliplatin infusion). The primary end point was time-to-treatment failure (TTF). RESULTS: One hundred thirty-nine patients were entered and treated up to the point of early study termination due to concerns by the data-monitoring committee (DMC) that Ca/Mg adversely affected tumor response. Tumor response was not a study end point. Given DMC concerns, an additional independent, blinded radiology review of all images showed no adverse effect of treatment schedule or Ca/Mg on response by Response Evaluation Criteria In Solid Tumors. The IO schedule was superior to CO [hazard ratio (HR) = 0.581, P = 0.0026] for both TTF and time-to-tumor progression (TTP) (HR = 0.533, P = 0.047). CONCLUSIONS: An IO dosing schedule had a significant benefit on both TTF and TTP versus CO dosing in this trial despite the very attenuated sample. There was no effect of Ca/Mg on response.